Publications

October 11, 2022

ESGCT – 2022 – Poster Presentation P150

Platform

Efficient knockout of both CD33 and CLL-1 by multiplex genome editing of human hematopoietic stem cells enhances the potential of next- generation transplants for acute myeloid leukemia (AML) treatment